Novation Pharmaceuticals


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Novation is focusing on the development of small molecular weight drugs that affect the stability of messenger RNA. Initial development efforts are on the treatment and prevention of cancer and chronic inflammatory diseases.

Novation is focusing on the development of small molecular weight drugs that affect the stability of messenger RNA. Initial development efforts are on the treatment and prevention of cancer and chronic inflammatory diseases.

Company (Alive / Active)

Phone:

Fax:

United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Novation Pharmaceuticals $0M Nov 30, 2018
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Novation Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Board Members

Competitors

Company Status Description Investors

GlycoMimetics

Gaithersburg, Maryland, United States
IPO / Went publicGlycoMimetics is developing small molecule drugs that mimic the actions of carbohydrates using glycobiology. The company is focusing its initial efforts on therapeutics to treat inflammatory diseases such as cystic fibrosis and cancer.Login to see details

Oxagen

Abingdon, United Kingdom
Alive / ActiveOxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.Login to see details
See all 19 competitors